NCT01293383View on ClinicalTrials.gov

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Healthy
Interventions
DRUG

LEO 90105

Ointment

Trial Locations (1)

812-0025

Hakata Clinic LTA Clinical Pharmacology Center, Fukuoka

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

LEO Pharma

INDUSTRY